Whitehawk Therapeutics (WHWK) Insider Hirmand Buys 38,040 Shares
Insider Mohammad Hirmand purchased 38,040 shares of WHWK on June 12, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Mohammad Hirmand bought 38,040 shares of Whitehawk Therapeutics, Inc. ($WHWK) on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $WHWK is up 7.2% after 1 week, down 7.7% after 1 month and down 30.5% to date (from the $4.16 close on Jun 12, 2026).
WHWK
Whitehawk Therapeutics, Inc.
Key Points
- On June 12, 2026, Mohammad Hirmand bought 38,040 shares of WHWK at a price of $0.00 per share.
- Shares of WHWK traded near $4.16, with several peer funds maintaining stable positions.
- Analysts from Citizens and Jones Trading initiated buy ratings with price targets of $8.00 and $7.00, respectively.
Get $WHWK trade alerts by text
We text you when insiders, Congress or big funds trade $WHWK. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Whitehawk Therapeutics, Inc. alert may contain errors. Disclosures
On June 12, 2026, Mohammad Hirmand made a significant move by purchasing 38,040 shares of WHWK. The shares were acquired at a price of $0.00, according to the transaction details. This insider buy adds to the company's overall insider activity, which included similar transactions by other insiders on the same date.
Other Institutional Activity in WHWK
While Mohammad Hirmand and other insiders were active in acquiring shares, several institutional investors maintained their holdings in WHWK. QVT Financial LP holds 4,615,709 shares valued at about $15.92 million. Orbimed Advisors LLC has a stake of 4,166,000 shares worth approximately $14.37 million. Suvretta Capital Management, LLC's position stands at 3,700,000 shares with a value of $12.77 million. Acuta Capital Partners, LLC holds 3,410,402 shares valued at $11.77 million, and Avoro Capital Advisors LLC owns 2,849,402 shares worth about $9.83 million. KVP Capital Advisors, LP maintains 2,165,997 shares, valued at $7.47 million.
Whitehawk Therapeutics, Inc. Stock Down 1.0%
Shares of WHWK are trading near $4.16. The company has seen stable interest from various institutional investors, as reflected in the unchanged holdings by several major funds.
Insider Buying and Selling at Whitehawk Therapeutics, Inc.
In addition to Mohammad Hirmand, several insiders purchased shares of WHWK on June 12, 2026. These include Caley Castelein, Neil Desai, Emma Reeve, Richard Maroun, Zhao Baiteng, and Behzad Aghazadeh, each acquiring 38,040 shares at a price of $0.00 per share. None of these transactions were planned under Rule 10b5-1.
Analysts Set New Price Targets
On April 16, 2026, Citizens initiated coverage on WHWK with a buy rating and an $8.00 price target. Earlier, on December 22, 2025, Jones Trading also initiated coverage with a buy rating, setting a price target of $7.00. The consensus among analysts reflects a positive outlook for WHWK, supported by these recent ratings.
Bottom Line
Mohammad Hirmand's recent purchase of WHWK shares highlights ongoing insider interest in the company. This activity, alongside stable institutional holdings, suggests a continued belief in the company's prospects. Analysts have shown optimism with new buy ratings and price targets, but remember that insider purchases are not always indicative of future performance.
Related Filing Alerts
Source: Mohammad Hirmand's Form 4 filing on $WHWK (Jun 12, 2026). Find the original filing: WHWK Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts